![](/img/cover-not-exists.png)
TP3 FACTORS ASSOCIATED WITH PRESCRIBING OF ORAL DISEASE MODIFYING AGENTS IN MULTIPLE SCLEROSIS
Earla, J.R., Hutton, G.J., Thornton, J.D., Aparasu, R.R.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.1907
Date:
May, 2019
File:
PDF, 324 KB
2019